Literature DB >> 15108282

Genetic characterization of myeloperoxidase deficiency in Italy.

Caterina Marchetti1, Pierluigi Patriarca, G Pietro Solero, Francisco E Baralle, Maurizio Romano.   

Abstract

Hereditary myeloperoxidase (MPO) deficiency (MPOD) is the most common neutrophil biochemical defect, and is characterized by a lack of peroxidase activity. In order to extend the epidemiological studies on hereditary MPOD in Italy, a population screening was carried out to detect mutations in the MPO gene. Of approximately 40,000 individuals analyzed, seven partial and eight total MPO-deficient subjects were identified. The genetic characterization of the subjects showed the presence of three already-known mutations (c.752T>C, c.1705C>T, and c.1566_1579del14) and six novel mutations: four missense mutations (c.995C>T, c.1112A>G, c.1715T>G, and c.1927T>C), then a deletion of an adenine within exon 3 (c.325delA) and a mutation within the 3' splice site of intron 11 (c.2031-2A>C). The novel missense mutations cause the substitution of the residues p.A332V, p.D371G, p.L572W, and p.W643R, respectively, and the potential structural changes are discussed. The c.325delA deletion causes a shift of the reading frame with the occurrence of a premature stop codon within the propeptide. Then, considering the difficulty in obtaining bone marrow samples from MPO-deficient subjects to study MPO mRNA splicing in vivo, we set up an eukaryotic expression system to investigate how the c.2031-2A>C mutation alters the MPO pre-mRNA splicing. The activation of a cryptic 3' splice site located 109nt upstream of the authentic 3' splice site was observed. The 109nt-insertion causes a shift in the reading frame that should lead to the generation of an abnormal MPO precursor lacking the enzymatic activity. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15108282     DOI: 10.1002/humu.20027

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  10 in total

1.  Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity.

Authors:  Kathleen D Metzler; Tobias A Fuchs; William M Nauseef; Dominique Reumaux; Joachim Roesler; Ilka Schulze; Volker Wahn; Venizelos Papayannopoulos; Arturo Zychlinsky
Journal:  Blood       Date:  2010-10-25       Impact factor: 22.113

2.  Myeloperoxidase Deficient Acute Promyelocytic Leukemia: Report of Two Cases.

Authors:  Pulkit Rastogi; Saniya Sharma; Sreejesh Sreedharanunni; Prashant Sharma; Man Updesh Singh Sachdeva; Richa Jain; Shano Naseem; Amit Trehan; Neelam Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2017-07-04       Impact factor: 0.900

3.  Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia.

Authors:  Alexander P Reiner; Jaana Hartiala; Tanja Zeller; Joshua C Bis; Josée Dupuis; Myriam Fornage; Jens Baumert; Marcus E Kleber; Philipp S Wild; Stephan Baldus; Suzette J Bielinski; João D Fontes; Thomas Illig; Brendan J Keating; Leslie A Lange; Francisco Ojeda; Martina Müller-Nurasyid; Thomas F Munzel; Bruce M Psaty; Kenneth Rice; Jerome I Rotter; Renate B Schnabel; W H Wilson Tang; Barbara Thorand; Jeanette Erdmann; David R Jacobs; James G Wilson; Wolfgang Koenig; Russell P Tracy; Stefan Blankenberg; Winfried März; Myron D Gross; Emelia J Benjamin; Stanley L Hazen; Hooman Allayee
Journal:  Hum Mol Genet       Date:  2013-04-24       Impact factor: 6.150

4.  Rare germline variant contributions to myeloid malignancy susceptibility.

Authors:  Samuel T Li; Janet Wang; Ruipeng Wei; Ruqi Shi; Vera Adema; Yasunobu Nagata; Cassandra M Kerr; Teodora Kuzmanovic; Bartlomiej Przychodzen; Francesc Sole; Jaroslaw P Maciejewski; Thomas LaFramboise
Journal:  Leukemia       Date:  2020-01-07       Impact factor: 11.528

5.  Myeloperoxidase deficiency: the secret under the flag of unstained cell.

Authors:  Türkan Patıroğlu; Hatice Eke Güngör; Julie Sawalle Belohradsky; Ekrem Unal; Christoph Klein
Journal:  Turk J Haematol       Date:  2013-06-05       Impact factor: 1.831

6.  Relationship between glycemic control and histochemical myeloperoxidase activity in neutrophils in patients with type 2 diabetes.

Authors:  Mustafa Unubol; Irfan Yavasoglu; Firuzan Kacar; Engin Guney; Imran Kurt Omurlu; Mevlut Ture; Gurhan Kadikoylu; Zahit Bolaman
Journal:  Diabetol Metab Syndr       Date:  2015-12-30       Impact factor: 3.320

7.  Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE).

Authors:  Faidra Parsopoulou; Gedeon Loules; Maria Zamanakou; Dorottya Csuka; Agnes Szilagyi; Maria Kompoti; Grzegorz Porebski; Fotis Psarros; Markus Magerl; Anna Valerieva; Maria Staevska; Krystyna Obtulowicz; Marcus Maurer; Matthaios Speletas; Henriette Farkas; Anastasios E Germenis
Journal:  Front Allergy       Date:  2022-07-07

8.  Prediction of the Effects of Missense Mutations on Human Myeloperoxidase Protein Stability Using In Silico Saturation Mutagenesis.

Authors:  Adebiyi Sobitan; William Edwards; Md Shah Jalal; Ayanfeoluwa Kolawole; Hemayet Ullah; Atanu Duttaroy; Jiang Li; Shaolei Teng
Journal:  Genes (Basel)       Date:  2022-08-08       Impact factor: 4.141

9.  Functional Defect of Neutrophils Causing Dermatophytosis: Case Report.

Authors:  Rosemeire N Constantino-Silva; Sandro F Perazzio; Nicolas de Albuquerque Weidebach; Anete S Grumach
Journal:  J Fungi (Basel)       Date:  2020-10-22

10.  Loss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin Disease.

Authors:  Marta Vergnano; Maja Mockenhaupt; Natashia Benzian-Olsson; Maren Paulmann; Katarzyna Grys; Satveer K Mahil; Charlotte Chaloner; Ines A Barbosa; Suzannah August; A David Burden; Siew-Eng Choon; Hywel Cooper; Alex A Navarini; Nick J Reynolds; Shyamal Wahie; Richard B Warren; Andrew Wright; Ulrike Huffmeier; Patrick Baum; Sudha Visvanathan; Jonathan N Barker; Catherine H Smith; Francesca Capon
Journal:  Am J Hum Genet       Date:  2020-08-05       Impact factor: 11.025

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.